COMMUNIQUÉS West-GlobeNewswire

SPINEWAY: Half-year financial statements 2024

23/09/2024 - 18:00

SPINEWAY Half-year financial statements 2024 Attachment Consolidated financial statements – 06 30 2024

SPINEWAY : Rapport semestriel 2024

23/09/2024 - 18:00

SPINEWAY Comptes semestriels 2024 et rapport d'activité Pièce jointe RFS_S12024

Crossject reports financial results and business highlights for the first six months of 2024

23/09/2024 - 18:00

Available cash €5.95 million, up from €2.3 million on December 31, 2023 Reports stable investments in R&D and consolidation of operating income from BARDA Company on track to successfully file for the Emergency Use [...]

Crossject présente ses résultats financiers et les faits marquants de ses activités pour le premier semestre 2024

23/09/2024 - 18:00

Position de trésorerie : 5,95 millions d'euros, contre 2,3 millions d’euros au 31 décembre 2023 Investissements stables en R&D et consolidation des revenus d'exploitation de BARDA La société est en bonne voie pour [...]

Spineway : Half-year results 2024

23/09/2024 - 18:00

SPINEWAY Half-year results 2024 Half-year turnover of €6.5 million (+20%) Improvement in operating income Full effect of savings measures visible in the 2nd half of 2024 In thousands of Euros Consolidated accounts S1 [...]

SPINEWAY :

23/09/2024 - 18:00

Communiqué de presse Ecully, le 23 septembre 2024 –18h SPINEWAY Résultats semestriels 2024 Chiffre d’affaires semestriel de 6,5 M€ (+ 20%) Amélioration du résultat d’exploitation Plein effet des mesures d’économies [...]

Canadian Animal Health Institute 2024 World Rabies Day Webinar: Event to feature leading experts on cross-border changes to pet travel, wildlife monitoring, and One Health strategies for rabies surveillance and control

23/09/2024 - 18:00

TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is excited to announce its 2024 World Rabies Day Webinar, happening on September 27, 2024. This year’s theme, “Breaking Rabies [...]

AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024

23/09/2024 - 17:51

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - FR0010557264 - AB) [...]

AB Science fait aujourd'hui le point sur le développement du masitinib dans les formes progressives de la sclérose en plaques suite à la conférence ECTRIMS 2024

23/09/2024 - 17:51

COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LE DÉVELOPPEMENT DU MASITINIB DANS LES FORMES PROGRESSIVES DE LA SCLÉROSE EN PLAQUES SUITE A LA CONFERENCE ECTRIMS 2024 Paris, le 23 septembre 2024, 17h45 CET AB Science [...]

UPDATE - MedCerts Launches Certified Nursing Assistant (CNA) eLearning Program Benefiting Medical Providers, Patients and Aspiring Healthcare Professionals

23/09/2024 - 17:41

New certification program features generative and conversational AI developed in-house, setting a new standard in healthcare training LIVONIA, Mich., Sept. 23, 2024 (GLOBE NEWSWIRE) -- In a release issued earlier today [...]

HNL Lab Medicine Relocates Route 61 Patient Service Center to Brunswick Business Center

23/09/2024 - 17:01

ALLENTOWN, Pa., Sept. 23, 2024 (GLOBE NEWSWIRE) -- HNL Lab Medicine is excited to announce the relocation of its Route 61 Patient Service Center from 1504 Pennsylvania 61, Pottsville, PA 17901 to the newly renovated [...]

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

23/09/2024 - 15:50

JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient, large-scale manufacture of [...]

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

23/09/2024 - 15:25

Investor Webcast on Tuesday, September 24, 2024 at 8:30 a.m. ET SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome- [...]

VR Helps Children with Autism Develop Social, Communication Skills, New Research Shows

23/09/2024 - 15:00

BlueSprig Pediatrics’ research featured in Behavior Analysis in Practice highlights potential for VR to successfully reconstruct re-world scenarios within learning programs HOUSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- [...]

PeopleOne Health and RosenCare Host Grand Opening of Orlando Health Center Serving Orange County Public School Employees

23/09/2024 - 15:00

Celebration marks the start of a four-center expansion in the Orlando area with key local leaders in attendance ORLANDO, Fla. and PITTSBURGH, Sept. 23, 2024 (GLOBE NEWSWIRE) -- PeopleOne Health , a trailblazer in value- [...]

Route 92 Medical Announces $50 Million Series F Extension Equity Financing

23/09/2024 - 15:00

Funds from Novo Holdings will support global commercial expansion Novo Holdings’ Noel Jee joins Route 92 Board of Directors SAN MATEO, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held [...]

Digital Utilities Ventures Reports Strong Fiscal Year 2024 - Advancing Leadership in Green Technologies

23/09/2024 - 15:00

MANKATO, Minn., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), a leader in sustainable energy and environmental technologies, recently announced its financial results and corporate [...]

T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture

23/09/2024 - 15:00

LEXINGTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted a [...]

Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference

23/09/2024 - 14:56

WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with [...]